To elucidate the pro-apoptotic effects of combination therapy involving doxo and HDAC inhibitors, namely Tas and PCI, in osteosarcoma cells, flow cytometry was used to assess apoptosis induction. Here, HDAC9 is linked to osteosarcoma.